TG Therapeutics Inc (NASDAQ:TGTX)

Delayed Data
As of Oct 29
 +0.48 / +1.85%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 47.00, with a high estimate of 65.00 and a low estimate of 38.00. The median estimate represents a +78.17% increase from the last price of 26.38.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.06%
Growthannually 8.42%


Growthquarterly -66.67%
Growthannually -0.88%
Key to the earnings and sales forecast charts.